DionyMed Brands Inc. Shares Approved to Trade on the OTCQB Venture Market under the Symbol ‘HMDEF’

TORONTO--()--DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME; OTCQB:HMDEF), a multi-state cannabis brands, distribution and delivery platform, announced today that its shares have been approved to be quoted on the OTCQB Venture Market and will trade under the symbol "HMDEF" effective immediately.

“DionyMed is pleased to begin trading on the OTCQB as our trading provides early direct access for U.S. investors to participate in the exciting growth of our company as we continue to expand into new U.S. markets from our primary markets in California and Oregon”, stated Edward Fields, CEO of DionyMed. “Our proprietary platform supports the design, development, distribution and marketing of award-winning brands at scale, and efficiently gets products into the hands of satisfied retailers and consumers in the markets we serve.”

DionyMed received conditional approval to list on the Canadian Securities Exchange (“CSE”) on November 22, 2018 and began trading on the CSE under the ticker symbol "DYME" on November 29, 2018.

Investors, media and other interested parties are invited to visit DionyMed’s Investor website at www.dionymed.com to view additional company information. To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands, distribution and delivery platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves more than 700 dispensaries and completes over 40,000 Direct-To-Consumer deliveries each month with its growing portfolio of products and brands. Learn more at www.DionyMed.com and follow @DYME_Inc on Twitter and LinkedIn.

Forward-Looking Information and Statements

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements, including but not limited to certain risk factors set out in the Listing Statement of the Company available on the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Contacts

Edward Fields, CEO
edward@dionymed.com
408-656-4209

Peter Kampian, CFO
pkampian@dionymed.com
416-209-5982

Investor Contacts:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contacts:
Kate Tumino / Annie Graf
KCSA Strategic Communications
212-896-1252 / 786-390-2644
ktumino@kcsa.com / agraf@kcsa.com

Release Summary

DionyMed Brands Inc. Shares Approved to Trade on the OTCQB Venture Market under the Symbol ‘HMDEF’

Contacts

Edward Fields, CEO
edward@dionymed.com
408-656-4209

Peter Kampian, CFO
pkampian@dionymed.com
416-209-5982

Investor Contacts:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contacts:
Kate Tumino / Annie Graf
KCSA Strategic Communications
212-896-1252 / 786-390-2644
ktumino@kcsa.com / agraf@kcsa.com